Autopsy report · NCT02301000

IMT for Primary Clostridium Difficile Infection

“Slow recruitment in pilot phase. A follow-up trial is launched (NCT03796650).”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 2 years 9 months before it stopped.
• 21 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2, Phase 3

Sponsor

Oslo University Hospital

Sponsor type

University, hospital or other

Conditions

Clostridium Difficile Infection

Interventions

Intestinal microbiota therapy; Metronidazole

Participants

21

Sites

7

Countries

Norway

Trials that died the same way

• Serum-derived Bovine Immunoglobulin Effect on Mucositis
  “Recruitment slower than anticipated” (77% match in meaning)
• IU Health Krannert Personalized Medicine Study
  “Slower than anticipated recruitment” (76% match in meaning)
• A Phase 1-2, Multicenter, Open-Label Study of AEG35156 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia and Indolent B-Cell Lymphomas
  “Slow recruitment” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.